- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
AstraZeneca Pharma India announces its 46th Annual General Meeting to approve annual financial results and a dividend of ₹32 per share for FY25. The company also proposes the appointment of Mr. Praveen Rao Akkinepally as its new Managing Director for a three-year term, effective July 1. Mr. Akkinepally brings over 20 years of commercial leadership, especially in Oncology and Biopharmaceuticals, with a strong track record of driving transformative business growth. His fixed annual remuneration will be around ₹3.18 Cr, plus variable performance bonus. This leadership change signals a continued focus on market expansion and strategic initiatives.